giikorea.co.kr
 È¨ | ȸ»ç¼Ò°³ | ¸ÂÃãÇü ½ÃÀåÁ¶»ç | ±¹Á¦ÄÁÆÛ·±½º | ±Û·Î¹ú ÆÄÆ®³Ê | īŻ·Î±× | E-mail Service | ¿¬¶ôó | Site Map

Conference banner
¿µ¾î ÀϺ»¾î TW
½ÃÀ庸°í¼­

2013³â±îÁöÀÇ ÅðÇ༺ ½Å°æÁúȯ ½ÃÀå ¿¹Ãø

Neurodegenerative Market Forecast to 2013

ÃâÆÇ»ç Cutting Edge Information Contact us : 02-2025-2992
ÃâÆÇÀÏ 2009/02
ÆäÀÌÁö  
º¸°í¼­ ÄÚµå 82015
°¡ °Ý £¤9,995 ÁÖ¹®°¡°Ý
£¤9,995 PDF by E-mail (Single User License)
£¤20,995 PDF By E-mail (Multi User License)
Delivery Time
PDF by E-Mail
ÁÖ¹®ÈÄ 1-2ÀÏ ³»¿¡ Email·Î º¸³»µå¸³´Ï´Ù.
Hard Copy/CD-ROM
¿µ¾÷ÀÏ ±âÁØ 5-7ÀÏ ÀüÈÄ·Î ÀÚ·á ¼ö·ÉÀÌ °¡´ÉÇÕ´Ï´Ù.

ÅðÇ༺ ½Å°æÁúȯ Ä¡·á¾àÀÇ °³¹ß µ¿Çâ°ú °æÇÕ, Àü·«Àû Æ÷Áö¼Å´×°ú ÇÔ²² ½ÃÀå ¼ºÀå±âȸ, ÀÓ»ó½ÃÇè µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

    1. °³¿ä
    • Á¶»ç¹æ¹ý
    • ÅðÇ༺ ½Å°æÁúȯ ½ÃÀå µ¿Çâ
    • ¹æ¹ý·Ð°ú Á¤ÀÇ
    2. ¾ËÃ÷ÇÏÀ̸Ӻ´
    • ¾Æ¼¼Æ¿Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦ ¾ïÁ¦Á¦
      • Aricept
      • Exelon
      • Razadyne
    • NMDA ±æÇ×Á¦
      • Namenda
      • Ebixa
    • ¾Æ¹Ð·ÎÀÌµå º£Å¸ Ä¡·á
      • Bapineuzumab
      • LY450139
      • LY2062430
      • ACC-001
    • ±âŸ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·á
    3. ´Ù¹ß¼º°æÈ­Áõ
    • ÀÎÅÍÆä·Ð º£Å¸
      • Avonex
      • Rebif
      • Betaseron
    • ¸é¿ªÁ¶ÀýÁ¦
      • Copaxone
      • Fingolimod/FIY720
      • BG-12
      • Laquinimod
      • °æ±¸ Leustatin
      • Teriflunomid/HMR1726
    • ´ÜÀÏŬ·ÐÇ×ü
      • HuMax-CD20
      • Campath
      • Rituxan/MabThera
      • Tysabri/Antegren
      • Firategrast/SB683699
    • ±âŸ Ä¡·á¹ý
    4. ÆÄŲ½¼º´
    • µµÆÄ¹Î ÀÛ¿ë¾à
      • Comtan
      • mirapex
      • Sinemet
      • Apokyn
      • Requib XL
    • ±âŸ Ä¡·á¹ý
      • Azilect/Agilect
      • ACP-103
      • Droxidopa
    5. µµÇ¥
ksm
Related Reports

Back to Top


| Home | Contact | E-mailing | About GII | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§| Site Map |
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç
Tel:02-2025-2992, Fax:02-2025-2993, E-mail :
(C) Copyright 2009 Global Information, Inc. All rights reserved.